लोड हो रहा है...
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
Avatrombopag is an orally-administered small molecule thrombopoietin receptor agonist. It was the third thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia and the first approved to treat periprocedural thrombocytopenia in patients with chronic liver disease (thereb...
में बचाया:
| में प्रकाशित: | J Blood Med |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Dove
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733339/ https://ncbi.nlm.nih.gov/pubmed/31565009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S191790 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|